 I mean, it really requires a strategy. There's another piece. So for example, ASPR has funded during the pandemic a number of manufacturers, but also glove manufacturers and drug manufacturers. But it's one thing to build a facility. The economics is still there. How are they to survive? There's actually an excellent article that I recommend you read in the pharmaceutical manufacturer that talks about how, you know, this is sort of